Patients with type 2 diabetes mellitus (T2DM) may also sustain brain damage in regions of the brain involved in cognition and emotion, a new study has found. This provides structural bases for mood and cognitive deficits in T2DM patients.
For patients with type 2 diabetes mellitus (T2DM), receiving text messages containing educational information or treatment reminders may help reduce HbA1c levels and improve medication adherence for at least 6 months, according to a meta-analysis.
In Japanese patients with type 2 diabetes (T2D), sodium-glucose cotransporter 2 inhibitors pose less of a cardiovascular risk than other glucose-lowering drugs and dipeptidyl peptidase-4 inhibitors, a new study has shown.
Healthy patients with significant fibrosis related to nonalcoholic fatty liver disease (NAFLD) are at a higher risk of developing type 2 diabetes mellitus (T2DM) and arterial hypertension (AHT), a recent study has shown.
In morbidly obese hospitalized patients, high-fixed dose unfractionated heparin for the prevention of venous thromboembolism is associated with a higher risk of major bleeding events compared with high-fixed dose enoxaparin, a recent study has shown.
It appears that light-to-moderate alcohol consumption (LMAC) can lower the risks of prevalent and incident type 2 diabetes mellitus (T2DM) in individuals without nonalcoholic fatty liver disease (NAFLD), suggests a study. However, LMAC increases the risk of T2DM in those with NAFLD.
A picosecond alexandrite laser (PSAL) appears to be superior to Q-switched alexandrite laser (QSAL) for the treatment of nevus of Ota, as shown by its better clinical results and fewer adverse events, according to a study.
Higher levels of plasma vitamin C, total and individual carotenoid biomarkers, and their composite biomarker score appear to reduce the incidence of type 2 diabetes (T2D), according to the results of a prospective case-cohort study in eight European countries.